TIGIT and type 1 diabetes mellitus: Our initial analyses indicate that TIGIT, an immunomodulatory receptor also expressed at high levels by CXCR5+PD1hi Tfh cells in blood and tonsils (Fig. 1; [12, 16]), shows promise as a candidate auxiliary marker for the identification of potentially pathogenic Tph cells in individuals with type 1 diabetes.